Name: Ovagen

Alias: EDL Tripeptide, Hepatic & Ovarian Bioregulator Peptide CAS Registry number: N/A Sequence: Glu-Asp-Leu-OH Molecular Formula: C??H??N?O? Molecular Weight: 375.37 Da Purity: ≥99% (by HPLC) Appearance: White lyophilized powder Packing: 20mg*10vials/box Product Group: Liver & ovarian epigenetic regulatory short peptide

Storage Conditions: Store at -20℃ in a dry, dark place; avoid repeated freeze-thaw cycles.

Brief Introduction:

Ovagen is a synthetic EDL tripeptide from Khavinson organ-specific bioregulator series, exclusively for laboratory research. It crosses cell and nuclear membranes to bind chromatin and regulate gene expression of hepatocytes and ovarian granulosa cells without relying on cell surface receptors. It protects liver cells from alcohol, chemical and oxidative damage, boosts hepatocyte regeneration, inhibits hepatic fibrosis and optimizes liver detoxification and lipid metabolism. Meanwhile, it delays ovarian aging, stabilizes follicular development, balances ovarian hormone secretion and alleviates oxidative injury of ovarian tissue. It also reinforces gastrointestinal mucosal barrier and reduces intestinal inflammatory infiltration. Widely applied in liver protection, hepatic fibrosis, female reproductive aging, ovarian function regulation and organ-targeted epigenetic peptide research.

Main Research Applications:

Hepatocyte protection research: Used in cell and animal models to study liver anti-oxidation, anti-fibrosis and hepatocyte regeneration mechanisms. Liver metabolism research: Explore liver detoxification promotion and lipid metabolism balance pathways. Ovarian aging research: Investigate follicular protection, ovarian hormone balance and reproductive senescence delay effects. Gastrointestinal mucosal research: Analyze intestinal barrier repair and chronic intestinal inflammation relief.

Organ bioregulator pharmacology research: Study chromatin-targeted gene regulation characteristics of dual liver-ovary short peptide.